(Image: Getty/CIPhotos)

Evotec licenses Ncardia’s disease modeling patents

By Melissa Fassbender

Ncardia has entered into a non-exclusive licensing agreement with Evotec through which the drug discovery solutions company will gain access to Ncardia’s stem cell derived cellular disease modeling IP.

The decision has implications for all CMOs and those companies with whom they partner. (Image: iStock/Zerbor)

The patent lives in Hospira v MedCo: good news for CMOs

By Melissa Fassbender

The Medicines Company announced last week that its Angiomax patent has been upheld – an 'important court decision' which affirms that working with CMOs won’t invalidate a company's patent.


Follow us


View more


Featured Suppliers

All suppliers